Glioblastoma: Clinical Trials

2 trials for Glioblastoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 enrolling by invitation. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Enrolling by invitation 2
Phase 11Enrolling by invitation 1

Follow Glioblastoma: new trials by email Literature Review of Glioblastoma trials Research Report on Glioblastoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sonodynamic-Chemoradiotherapy Integration in Glioblastoma
Sonodynamic Therapy (SDT), Standard Treatment - Glioblastoma (GBM)
Phase 2Enrolling by invitationYingjuan Zheng2302024-10-012025-08-19
Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
PET/CT ([18F]AlF-NOTA-PCP2), [18F]AlF-NOTA-PCP2 PET/CT Imaging for PD-L1 Expression in Malignant Tumors - Glioblastoma (GBM), Head and Neck Squamous Cell Carcinoma
Phase 1 / Phase 2Enrolling by invitationMan Hu1002024-03-302025-03-30

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)  ·  Esophageal Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Astrocytoma (2)  ·  Glioma (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neoplasms, Neuroepithelial (2)  ·  Neuroectodermal Tumors (2)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Bronchogenic (1)  ·  Carcinoma, Squamous Cell (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)

Sponsors

Man Hu (1)  ·  Yingjuan Zheng (1)

Countries

China (2)

Top investigators

Man Hu, Dr. (1)

Results publications

PMID 38291578, PMID 38713298